Matthieu D. Lavigne

Matthieu D. Lavigne

Auto-generated profile, based on publicly available information

Matthieu D. Lavigne

Institute of Molecular Biology and Biotechnology (IMBB), Foundation for Research and Technology-Hellas (FORTH), Heraklion, Greece

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
MLMatthieu D. Lavigne
Matthieu D. Lavigne
DKDimitris Konstantopoulos
Dimitris Konstantopoulos
KNKaterina Z. Ntakou-Zamplara
Katerina Z. Ntakou-Zamplara
ALAnastasios Liakos
Anastasios Liakos
MFMaria Fousteri
Maria Fousteri
Complex molecular responses preserve gene expression accuracy and genome integrity in the face of environmental perturbations. Here we report that, in response to UV irradiation, RNA polymerase II (RNAPII) molecules are dynamically and synchronously released from promoter-proximal regions into elongation to promote uniform and accelerated surveillance of the whole transcribed genome. The maximised influx of de novo released RNAPII correlates with increased damage-sensing, as confirmed by RNAPII progressive accumulation at dipyrimidine sites and by the average slow-down of elongation rates in gene bodies. In turn, this transcription elongation ‘safe’ mode guarantees efficient DNA repair regardless of damage location, gene size and transcription level. Accordingly, we detect low and homogenous rates of mutational signatures associated with UV exposure or cigarette smoke across all active genes. Our study reveals a novel advantage for transcription regulation at the promoter-proximal level and provides unanticipated insights into how active transcription shapes the mutagenic landscape of cancer genomes.

1 November 2005 in Journal of Controlled Release
Verified
Journal Article
Closed access
BTBeverley R. Twaites
Beverley R. Twaites
CACarolina de Las Heras Alarcón
Carolina de Las Heras Alarcón
MLMatthieu Lavigne
Matthieu Lavigne
ASAnnabelle Saulnier
Annabelle Saulnier
SPSivanand S. Pennadam
Sivanand S. Pennadam
CACameron Alexander
Cameron Alexander

26 July 2022 in Genome Medicine
Verified
Journal Article
Open access
PDF file
MAMaria ARMAKA
Maria ARMAKA
DKDimitris Konstantopoulos
Dimitris Konstantopoulos
CTChristos Tzaferis
Christos Tzaferis
MLMatthieu D. Lavigne
Matthieu D. Lavigne
MSMaria Sakkou
Maria Sakkou
GKGeorge Kollias
George Kollias
Background: Synovial fibroblasts (SFs) are specialized cells of the synovium that provide nutrients and lubricants for the proper function of diarthrodial joints. Recent evidence appreciates the contribution of SF heterogeneity in arthritic pathologies. However, the normal SF profiles and the molecular networks that govern the transition from homeostatic to arthritic SF heterogeneity remain poorly defined. Methods: We applied a combined analysis of single-cell (sc) transcriptomes and epigenomes (scRNA-seq and scATAC-seq) to SFs derived from naïve and hTNFtg mice (mice that overexpress human TNF, a murine model for rheumatoid arthritis), by employing the Seurat and ArchR packages. To identify the cellular differentiation lineages, we conducted velocity and trajectory analysis by combining state-of-the-art algorithms including scVelo, Slingshot, and PAGA. We integrated the transcriptomic and epigenomic data to infer gene regulatory networks using ArchR and custom-implemented algorithms. We performed a canonical correlation analysis-based integration of murine data with publicly available datasets from SFs of rheumatoid arthritis patients and sought to identify conserved gene regulatory networks by utilizing the SCENIC algorithm in the human arthritic scRNA-seq atlas. Results: By comparing SFs from healthy and hTNFtg mice, we revealed seven homeostatic and two disease-specific subsets of SFs. In healthy synovium, SFs function towards chondro- and osteogenesis, tissue repair, and immune surveillance. The development of arthritis leads to shrinkage of homeostatic SFs and favors the emergence of SF profiles marked by Dkk3 and Lrrc15 expression, functioning towards enhanced inflammatory responses and matrix catabolic processes. Lineage inference analysis indicated that specific Thy1+ SFs at the root of trajectories lead to the intermediate Thy1+/Dkk3+/Lrrc15+ SF states and culminate in a destructive and inflammatory Thy1− SF identity. We further uncovered epigenetically primed gene programs driving the expansion of these arthritic SFs, regulated by NFkB and new candidates, such as Runx1. Cross-species analysis of human/mouse arthritic SF data determined conserved regulatory and transcriptional networks. Conclusions: We revealed a dynamic SF landscape from health to arthritis providing a functional genomic blueprint to understand the joint pathophysiology and highlight the fibroblast-oriented therapeutic targets for combating chronic inflammatory and destructive arthritic disease.

1 November 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
AAAthina Antonaki
Athina Antonaki
CDConstantinos Demetriades
Constantinos Demetriades
APAlexander Polyzos
Alexander Polyzos
ABAggelos Banos
Aggelos Banos
GVGiannis Vatsellas
Giannis Vatsellas
DTDimitris Thanos
Dimitris Thanos
The transcription factor NF-kappa B is a critical regulator of immune responses. To determine how NF-kappa B builds transcriptional control networks, we need to obtain a topographic map of the factor bound to the genome and correlate it with global gene expression. We used a ChIP cloning technique and identified novel NF-kappa B target genes in response to virus infection. We discovered that most of the NF-kappa B-bound genomic sites deviate from the consensus and are located away from conventional promoter regions. Remarkably, we identified a novel abundant NF-kappa B-binding site residing in specialized Alu-repetitive elements having the potential for long range transcription regulation, thus suggesting that in addition to its known role, NF-kappa B has a primate-specific function and a role in human evolution. By combining these data with global gene expression profiling of virus-infected cells, we found that most of the sites bound by NF-kappa B in the human genome do not correlate with changes in gene expression of the nearby genes and they do not appear to function in the context of synthetic promoters. These results demonstrate that repetitive elements interspersed in the human genome function as common target sites for transcription factors and may play an important role in expanding the repertoire of binding sites to engage new genes into regulatory networks.

25 September 2004 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
SPSivanand S. Pennadam
Sivanand S. Pennadam
MLMatthieu D. Lavigne
Matthieu D. Lavigne
CDChristina F. Dutta
Christina F. Dutta
KFKeith Firman
Keith Firman
DMDarren Mernagh
Darren Mernagh
CACameron Alexander
Cameron Alexander

16 April 2012 in Oncogene
Verified
Journal Article
Closed access
IFIosifina Petrina Foskolou
Iosifina Petrina Foskolou
DSDimitrios Stellas
Dimitrios Stellas
IRI Rozani
I Rozani
MLM D Lavigne
M D Lavigne
PPP K Politis
P K Politis